Stifel Reiterates Hold on National Health Investors, Maintains $55 Price Target
Portfolio Pulse from Benzinga Newsdesk
Stifel analyst Stephen Manaker has reiterated a 'Hold' rating on National Health Investors (NYSE:NHI) and maintained a $55 price target for the company's stock.
November 28, 2023 | 5:18 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Stifel analyst Stephen Manaker reiterated a 'Hold' rating on National Health Investors and maintained a $55 price target.
The reiteration of a 'Hold' rating and maintenance of the existing price target by Stifel suggests no significant change in the company's outlook or performance. This typically does not have a substantial short-term impact on the stock price, as it reflects a continuation of the analyst's previous stance.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100